Articles for author: Russ Cohen

Russ Cohen

5 Monster Stocks — Such as Coupang — to Hold for the Next 10 Years

A “monster stock” might be one that frightens you by free-falling. Or it might alarm you with characteristics such as plummeting sales, shrinking profit margins, or surging debt. We’ll use a different definition for this article. We’ll consider monster stocks to be ones that have actually performed very well and/or are likely to continue doing ...

Russ Cohen

NVDA vs. AMD: Which Semiconductor Stock is the Smarter AI Play in 2025?

NVIDIA Corporation NVDA and Advanced Micro Devices, Inc. AMD are at the center of the artificial intelligence (AI) hardware boom. Both companies make the graphics processing units (GPUs) and AI accelerators that train large language models, power cloud servers and drive modern computing. However, as U.S. tariffs and new export restrictions weigh on tech sentiment, ...

Russ Cohen

Every Nvidia Investor Should Keep an Eye on This Number

Nvidia (NASDAQ: NVDA) has been one of the hottest stocks on the market for the past couple of years, up an absurd 610% since the start of 2023 (as of April 16). Nvidia’s historic run can be attributed to one thing: artificial intelligence (AI). AI has taken the world by storm, and Nvidia is one ...

Russ Cohen

NBIS vs. MSFT: Which AI Infrastructure Stock is the Better Buy?

Nebius Group N.V. NBIS is an upcoming player in the AI-infrastructure market, while Microsoft Corporation MSFT is an established tech behemoth. Microsoft’s Azure cloud platform is the second-largest cloud platform after Amazon Web Services or the AWS platform. MSFT’s investment in OpenAI has made it the go-to platform for innovative AI applications. The rapid AI ...

Russ Cohen

Deadline Approaching: Canopy Growth Corporation (CGC) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming June 3, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Canopy Growth Corporation (“Canopy” or the “Company”) CGC securities between May 30, 2024 and February 6, 2025, inclusive (the “Class Period”). IF YOU ARE ...

Russ Cohen

Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories (NYSE:) is not immune to the impact of tariffs on its medical device business. However, the company’s diversified business is tariff-resistant, and moves are being made to strengthen it further. Those include a $500 million investment in two domestic manufacturing facilities expected to go live by year’s end. The facilities are located in ...

Russ Cohen

Netflix Could Jump 139% in 5 Years, According to Management

Netflix (NASDAQ: NFLX) is one of the best-performing stocks of the 21st century, and it’s been one of the biggest surprises over the last three years. The streaming giant was left for dead in 2022 after it reported two straight quarters of declining subscriber growth in the aftermath of the pandemic. Since then, the company ...